Jazz Pharmaceuticals plc Revenue 2009–2025
Jazz Pharmaceuticals plc annual/quarterly revenue history and growth rate from 2009 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Jazz Pharmaceuticals plc revenue for the quarter ending March 31, 2026 was 1.1 B, a 19.06% increase year-over-year.
- Jazz Pharmaceuticals plc revenue for the twelve months ending March 31, 2026 was 4.1 B, a 4.70% increase year-over-year.
- Jazz Pharmaceuticals plc annual revenue for 2025 was 4.3 B, a 4.88% increase from 2024.
- Jazz Pharmaceuticals plc annual revenue for 2024 was 4.1 B, a 6.12% increase from 2023.
- Jazz Pharmaceuticals plc annual revenue for 2023 was 3.8 B, a 4.78% increase from 2022.
- Jazz Pharmaceuticals plc annual revenue for 2022 was 3.7 B.
Jazz Pharmaceuticals plc (JAZZ) — Frequently Asked Questions
Jazz Pharmaceuticals plc (JAZZ) is a publicly traded US company. It has a market capitalization of $14.40B. In fiscal 2025 it reported revenue of $4.27B and net income of -$356M. Explore JAZZ's stock price, financial statements, earnings history, margins and key ratios below.
What is Jazz Pharmaceuticals plc's market cap?
Jazz Pharmaceuticals plc (JAZZ) has a market capitalization of $14.40B.
What is the JAZZ stock price?
JAZZ trades at $236.17 (+2.85% on the day).
How much revenue does Jazz Pharmaceuticals plc make?
Jazz Pharmaceuticals plc reported revenue of $4.27B in fiscal 2025.
Is JAZZ profitable?
In fiscal 2025, Jazz Pharmaceuticals plc reported net income of -$356M.